FDA Brief

Warning letters Drugs

FDA warning letter to

All American Wellness

LowIssued Sep 9, 2025Posted Sep 16, 2025Center for Drug Evaluation and Research (CDER)

FDA warned telehealth seller All American Wellness that its website wrongly compares compounded semaglutide and tirzepatide to Ozempic and Mounjaro.

What happened

FDA reviewed the website all-american-wellness.com in August 2025 and found it offering compounded semaglutide and tirzepatide drug products. The site described them as "Ozempic's compounded version- Semaglutide" and "Mounjaro's compounded version- Tirzepatide." FDA said those statements falsely imply the compounded products are the same as FDA-approved drugs, which they are not, making them misbranded.

What FDA found

  1. Website claims that falsely imply a compounded drug is the same as an FDA-approved drug make the product misbranded.

    FDCA section 502(a) [21 U.S.C. § 352(a)]
  2. Advertising or promotion for a compounded drug that is false or misleading in any way makes it misbranded.

    FDCA section 502(bb) [21 U.S.C. § 352(bb)]
  3. Shipping misbranded drugs across state lines is a prohibited act.

    FDCA section 301(a) [21 U.S.C. § 331(a)]
  4. Receiving misbranded drugs in interstate commerce, or delivering them, is also prohibited.

    FDCA section 301(c) [21 U.S.C. § 331(c)]

What FDA wants

FDA tells the company to stop using the brand-comparison language immediately and to send the Office of Compounding Quality and Compliance a written account of the corrective steps taken, with supporting documents, within 15 working days.

Who should pay attention

  • telehealth and online prescriber platforms selling compounded GLP-1 drugs
  • compounding pharmacies and the marketing partners that write their website copy
  • companies that name a brand drug when describing a compounded alternative

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low